Association of obesity with heart failure outcomes in 11 Asian regions:A cohort study by 
  
 University of Groningen






IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2019
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
ASIAN-HF Investigators (2019). Association of obesity with heart failure outcomes in 11 Asian regions: A
cohort study. PLOS MEDICINE, 16(9), [1002916]. https://doi.org/10.1371/journal.pmed.1002916
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 11-12-2019
RESEARCH ARTICLE
Association of obesity with heart failure
outcomes in 11 Asian regions: A cohort study
Chanchal ChandramouliID1, Wan Ting TayID1, Nurul Sahiddah Bamadhaj1,
Jasper Tromp1,2, Tiew-Hwa Katherine Teng1, Jonathan J. L. YapID1, Michael
R. MacDonaldID3, Chung-Lieh HungID4, Koen Streng2, Ajay NaikID5, Gurpreet
Singh WanderID6, Jitendra Sawhney7, Lieng Hsi LingID8, A. Mark Richards8, Inder Anand9,
Adriaan A. Voors2, Carolyn S. P. LamID1,2,10*, on behalf of ASIAN-HF Investigators¶
1 National Heart Centre Singapore, Singapore, Singapore, 2 University Medical Center Groningen,
Groningen, Netherlands, 3 Changi General Hospital, Singapore, Singapore, 4 MacKay Memorial Hospital,
Taipei, Taiwan, 5 CIMS Hospital, Ahmedabad, Gujarat, India, 6 Dayanand Medical College and Hospital,
Ludhiana, Punjab, India, 7 Sir Gangaram Hospital, New Delhi, India, 8 Cardiovascular Research Institute,
Singapore, Singapore, 9 Veterans Affairs Medical Center, Minneapolis, Minnesota, United States of America,
10 Duke-NUS Medical School, Singapore, Singapore




Asians are predisposed to a lean heart failure (HF) phenotype. Data on the ‘obesity para-
dox’, reported in Western populations, are scarce in Asia and have only utilised the tradi-
tional classification of body mass index (BMI). We aimed to investigate the association
between obesity (defined by BMI and abdominal measures) and HF outcomes in Asia.
Methods and findings
Utilising the Asian Sudden Cardiac Death in Heart Failure (ASIAN-HF) registry (11 Asian
regions including Taiwan, Hong Kong, China, India, Malaysia, Thailand, Singapore, Indone-
sia, Philippines, Japan, and Korea; 46 centres with enrolment between 1 October 2012 and
6 October 2016), we prospectively examined 5,964 patients with symptomatic HF (mean
age 61.3 ± 13.3 years, 26% women, mean BMI 25.3 ± 5.3 kg/m2, 16% with HF with pre-
served ejection fraction [HFpEF; ejection fraction� 50%]), among whom 2,051 also had
waist-to-height ratio (WHtR) measurements (mean age 60.8 ± 12.9 years, 24% women,
mean BMI 25.0 ± 5.2 kg/m2, 7% HFpEF). Patients were categorised by BMI quartiles or
WHtR quartiles or 4 combined groups of BMI (low, <24.5 kg/m2 [lean], or high,�24.5 kg/m2
[obese]) and WHtR (low, <0.55 [thin], or high,�0.55 [fat]). Cox proportional hazards models
were used to examine a 1-year composite outcome (HF hospitalisation or mortality). Across
BMI quartiles, higher BMI was associated with lower risk of the composite outcome (ptrend <
0.001). Contrastingly, higher WHtR was associated with higher risk of the composite out-
come. Individuals in the lean-fat group, with low BMI and high WHtR (13.9%), were more
likely to be women (35.4%) and to be from low-income countries (47.7%) (predominantly in
South/Southeast Asia), and had higher prevalence of diabetes (46%), worse quality of life
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scores (63.3 ± 24.2), and a higher rate of the composite outcome (51/232; 22%), compared
to the other groups (p < 0.05 for all). Following multivariable adjustment, the lean-fat group
had higher adjusted risk of the composite outcome (hazard ratio 1.93, 95% CI 1.17–3.18, p
= 0.01), compared to the obese-thin group, with high BMI and low WHtR. Results were con-
sistent across both HF subtypes (HFpEF and HF with reduced ejection fraction [HFrEF]; pin-
teraction = 0.355). Selection bias and residual confounding are potential limitations of such
multinational observational registries.
Conclusions
In this cohort of Asian patients with HF, the ‘obesity paradox’ is observed only when defined
using BMI, with WHtR showing the opposite association with the composite outcome. Lean-
fat patients, with high WHtR and low BMI, have the worst outcomes. A direct correlation
between high WHtR and the composite outcome is apparent in both HFpEF and HFrEF.
Trial registration
Asian Sudden Cardiac Death in HF (ASIAN-HF) Registry ClinicalTrials.gov Identifier:
NCT01633398
Author summary
Why was this study done?
• Asian heart failure (HF) patients are more likely to have a lean HF phenotype compared
to Western patients.
• The obesity paradox, where higher body mass index (BMI) is associated with better HF
outcomes, is well-reported in Western populations, but little is known about this para-
dox in Asia.
• We investigated the association between obesity, defined by traditional BMI versus
waist circumference indices, and HF outcomes in Asia.
What did the researchers do and find?
• Among Asian patients with HF, BMI and waist-to-height ratio (WHtR) have direction-
ally opposite relationships with a composite outcome of all-cause death and hospitalisa-
tion for HF—lower BMI, but higher WHtR, is associated with worse outcomes.
• In combined analysis, patients who were lean-fat (with low BMI but high WHtR) were
more likely to be women, to be from low-income countries or South/Southeast Asia, to
have diabetes, and to have worse quality of life scores.
• Lean-fat patients also had the highest rate and risk of the composite outcome (HF hospi-
talisation and all-cause mortality), irrespective of heart failure subtype (with preserved
versus reduced ejection fraction).
Association of obesity with heart failure outcomes in Asia
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What do these findings mean?
• The obesity paradox exists in Asia only when obesity is classified by BMI.
• The relationship between obesity and HF outcomes in Asia is directionally opposite for
BMI versus WHtR.
• In this cohort of Asian patients with HF, lean (low BMI) patients with central obesity
(high WHtR) had the worst outcomes, both in cases where ejection fraction was reduced
and in cases where it was preserved.
Introduction
Obesity poses a major public health challenge globally, affecting 650 million worldwide, with a
worrisome tripling of its prevalence over the last 20 years, especially among young adults in
low- and middle-income countries [1]. Ethnic differences in the association of body mass
index (BMI) with clinical outcomes have been observed in the general population, with Asians
being at higher risk of adverse events at lower BMI cutoffs compared to international stan-
dards [2]. WHO has therefore recommended lower BMI cutoffs for the definition of obesity
and clinical preventive efforts among Asians [3].
Obesity is an antecedent risk factor of heart failure (HF). In established HF, however, a par-
adoxical relationship between obesity and outcomes has been described, where obese HF
patients (defined by higher BMI) have better outcomes compared to those with lower BMI.
This ‘obesity paradox’ was described mainly in Western cohorts of patients with HF with pre-
served ejection fraction (HFpEF) or HF with reduced ejection fraction (HFrEF) [4–6], and in
limited Asian populations with HFrEF [7,8]. Of note, we recently showed that Asians, particu-
larly in Southeast Asia, are predisposed to a unique lean diabetic HFpEF phenotype [9], with
the worst outcomes among all HF phenotypes, including ischemic and non-ischemic HFrEF.
Moreover, BMI is known to be a remarkably heterogeneous parameter and does not account
for body fat distribution [10]. Consideration of body fat distribution has gained momentum in
recent years, with obesity measures other than BMI—including waist circumference, waist-to-
hip ratio, waist-to-height ratio (WHtR), and body fat percentage—having better discrimina-
tory capacity than BMI in predicting cardiovascular outcomes [11,12]. Findings from TOP-
CAT (Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone
Antagonist) showed greater risk of mortality among HFpEF patients with higher waist circum-
ference (�102 cm in men,�88 cm in women) [13]. Similarly, in BIOSTAT-CHF (BIOlogy
Study to TAilored Treatment in Chronic Heart Failure), higher waist-to-hip ratio was linked
to higher risk of death in women [14]. There is a lack of data on waist circumference measure-
ments in Asian patients with HF, and prior data using BMI are limited to HFrEF in Asia.
Therefore, we sought to examine the association of obesity, defined by BMI versus waist cir-
cumference, with HF outcomes in patients with HFpEF and HFrEF in Asia.
Methods
Study design, study population, and setting
This study adheres to the Strengthening the Reporting of Observational Studies in Epidemiol-
ogy (STROBE) guidelines (S1 Checklist). Ethics approvals were obtained from the relevant
Association of obesity with heart failure outcomes in Asia
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human ethics committees at all sites (S1 Table). The study complied with the Declaration of
Helsinki, and all patients provided written informed consent.
We studied the association of obesity with outcomes using the Asian Sudden Cardiac Death
in Heart Failure (ASIAN-HF) registry [2,15]. The prospective study design, with details on
sample size, of the ASIAN-HF registry has been published previously [15]. Briefly, ASIAN-HF
is a prospective observational multinational registry with patients with HF from 46 investiga-
tion sites in 11 Asian regions (Taiwan, Hong Kong, China, India, Malaysia, Thailand, Singa-
pore, Indonesia, Philippines, Japan, and Korea) that enrolled patients between 1 October 2012
and 6 October 2016 (S1 Text). The broad purpose of the ASIAN-HF registry was to determine
the characteristics, mortality/morbidity, and risk factors for adverse outcomes among Asian
patients with symptomatic HF (stage C). Although the specific primary analysis described in
the study design [15] related to investigating sudden cardiac death in HFrEF [16], prespecified
aims also included examining risk factors for outcomes (including both deaths and hospitalisa-
tions), as well as assessing the thresholds of traditional risk factors that are associated with
increased risk in Asian patients.
The recruitment of patients with HFpEF was delayed by 1 year (9 September 2013 versus 1
October 2012) relative to the recruitment of patients with HFrEF, for funding reasons. For
most of the recruitment period (until 6 October 2016), there was overlap in recruitment of
both types of HF, and no apparent shifts in epidemiology were expected. Feasibility of follow-
up throughout the duration of the study through periodic contact was ensured. The key inclu-
sion criteria were>18 years of age with symptomatic HF (at least 1 previous episode of decom-
pensated HF in the previous 6 months resulting in a hospital admission or treatment in an
outpatient clinic). Patients with severe valvular heart disease as a cause of HF, with a life-
threatening comorbidity with a life expectancy < 1 year, or who were unable or unwilling to
give consent were excluded. All patients underwent physical examination at baseline: Waist
circumference was measured in n = 2,051 patients, and BMI measurements were available for
the entire cohort (n = 5,964).
Study definitions
Patients were grouped by (1) BMI quartiles (<21.8, 21.8 to<24.5, 24.5 to<27.8, and�27.8
kg/m2), (2) WHtR quartiles (<0.51, 0.51 to<0.55, 0.55 to<0.60, and�0.60), and (3) 4 com-
bined anthropometric groups of BMI (high,�24.5 kg/m2 [obese], or low,<24.5 kg/m2 [lean])
and WHtR (high,�0.55 [fat], or low,<0.55 [thin]) (Fig 1).
The definitions of comorbidities in ASIAN-HF have been previously described [2,15]. Cor-
onary artery disease was defined as significant coronary obstruction on angiography, history
of myocardial infarction, or prior revascularization. Hypertension was defined as the clinical
diagnosis (blood pressure� 140/90 mm Hg) and/or receiving anti-hypertensive medication.
Diabetes was defined as prior history of diabetes and/or receiving anti-diabetic therapy. The
Modification of Diet in Renal Disease (MDRD) Study equation was utilised to compute esti-
mated glomerular filtration rate (eGFR), and chronic kidney disease was defined as
eGFR< 60 ml/min/1.73 m2. Health status was measured using the Kansas City Cardiomyopa-
thy Questionnaire (KCCQ), a validated 23-item patient-centred HF-specific questionnaire
[17]. Higher KCCQ domain scores (0 to 100) represent better health status.
Body composition analysis
In a group of HF patients recruited in Singapore (n = 311), bioelectrical impedance analysis
was performed (InBody370; InBody, Cerritos, CA, US). Body weight, skeletal muscle mass, fat
mass, and estimated trunk fat were measured using the direct segmental (right arm, left arm,
Association of obesity with heart failure outcomes in Asia
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002916 September 24, 2019 4 / 17
trunk, right leg, left leg) method at 3 different frequencies (5 kHz, 50 kHz, and 250 kHz), as
described previously [18]. The variables trunk fat, skeletal muscle, and fat mass were calculated
as percentage of body weight. In separate regression models, each of these body composition
parameters was treated as the dependent variable, while waist-to-hip ratio was the independent
variable, with the model adjusted for age, sex, and BMI.
Outcomes
Patients were followed up for protocol-defined outcomes, which were adjudicated by an inde-
pendent clinical endpoint committee. The primary outcome was the composite of 1-year all-
cause mortality or hospitalisation for HF. Secondary outcomes were 1-year all-cause mortality,
1-year HF hospitalisation, 1-year cardiovascular mortality, and health-related quality of life
(QoL) assessed with the KCCQ assessed at baseline. As a sensitivity analysis, the association of
BMI and outcomes was also examined using WHO-recommended Asian cutoffs (<18.5, 18.5
to<23.0, 23.0 to<27.5, and�27.5 kg/m2 for underweight, normal, overweight, and obese,
respectively) in the whole cohort with follow-up data (n = 5,397). All data were prospectively
documented in an electronic database capture, which was managed by a contract research
organisation (IQVIA, formerly Quintiles) appointed by the academic executive committee.
Statistical analysis
Baseline characteristics for the groups of patients were described using frequencies with per-
centages for categorical variables and means with standard deviations for continuous variables.
Differences between groups were tested using Pearson χ2 tests for categorical variables and
ANOVA for continuous variables. A test of trend across the quartiles of WHtR and BMI was
also performed. Restricted cubic regression splines were used to examine the association of
BMI and WHtR with the composite outcome. Time-to-event analyses were examined using
Fig 1. Central illustration of 4 combined groups of BMI (high,�24.5 kg/m2 [obese], or low,<24.5 kg/m2 [lean])
and waist-to-height ratio (high,�0.55 [fat], or low,<0.55 [thin]). QoL refers to the Kansas City Cardiomyopathy
Questionnaire total symptom score. Key differences in characteristics between BMI/WHtR groups in bold. abv, above;
BMI, body mass index; HFpEF, heart failure with preserved ejection fraction; NYHA, New York Heart Association;
QoL, quality of life; WHtR, waist-to-height ratio.
https://doi.org/10.1371/journal.pmed.1002916.g001
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multivariable Cox proportional hazards models in the absence of violation of the proportional
hazards assumption. Adjustments included age, sex, ethnicity, enrolment type (recruited dur-
ing inpatient stay versus at outpatient clinic), New York Heart Association (NYHA) class, sys-
tolic blood pressure, heart rate, ejection fraction (EF), history of coronary artery disease, atrial
fibrillation, diabetes, peripheral oedema, peripheral arterial vascular disease, and use of an
angiotensin-converting enzyme inhibitor (ACEi)/angiotensin receptor blocker (ARB), beta
blocker, diuretic, or mineralocorticoid receptor antagonist (MRA). The primary endpoint of
1-year all-cause mortality or HF hospitalisation was censored at 1 year or the last date of fol-
low-up, whichever was earlier, in patients who did not have an event. To determine if HF sub-
type (i.e., HFrEF [EF< 40%] or HFpEF [EF� 50%]) modified the relationship between
obesity and HF outcomes, the interaction between HF subtype and BMI/WHtR/combined
anthropometric groups, adjusted for age, was examined in the Cox model. Sensitivity analysis
of the relationship between BMI and HF outcomes was performed in the entire cohort. Mar-
ginal KCCQ domain scores, adjusted for age, sex, ethnicity, enrolment type, education, NYHA
class, systolic blood pressure, heart rate, HF subtype, history of coronary artery disease, atrial
fibrillation, and diabetes, were examined. In view of a reviewer’s suggestion, sex-stratified anal-
ysis of the association of WHtR with HF outcomes was also performed.
Patients with incomplete data on adjusted clinical and demographic factors were excluded
from multivariable logistic and Cox regression analyses. All analyses were performed with
Stata/SE version 14.0 (StataCorp, College Station, TX, US).
Results
Baseline characteristics
In the entire cohort of 5,964 Asian patients with HF (mean age 61.3 ± 13.3 years, 26% women,
16% HFpEF), with increasing BMI category (WHO-recommended Asian cutoffs), patients
were younger, with higher blood pressure, larger waist measures, greater prevalence of comor-
bidities (hypertension, diabetes and peripheral oedema), and higher QoL scores (ptrend < 0.05;
S2 Table).
Asian patients with HF with (versus without) waist measures available were marginally
younger (60.8 ± 12.9 versus 61.6 ± 13.5 years, p = 0.018), had a lower prevalence of HFpEF
(6.8% versus 20.8%), belonged to less severe NYHA classes (68.5% versus 66.2%), had similar
heart rate (78.8 ± 14.8 versus 78.8 ± 16.2 bpm), had similar BMI (25.0 ± 5.2 versus 25.4 ± 5.4
kg/m2), and had similar prevalence of both chronic kidney disease (43.7% versus 46.4%) and
diabetes (40.4% versus 41.7%) (S3 Table; p> 0.05 for all).
Among 2,051 Asian patients with HF who had both BMI and WHtR measurements (mean
age 60.8 ± 12.9 years, 24% women, 7% HFpEF), mean BMI and waist circumference were
25.0 ± 5.2 kg/m2 and 91.1 ± 12.5 cm; the 5th and 95th percentiles of BMI and WHtR were
18.3–34.2 kg/m2 and 0.45–0.70, respectively. Patients with HFpEF, compared to HFrEF, had
higher mean BMI (27.1 ± 6.0 versus 24.2 ± 5.1 kg/m2) and waist circumference (98.2 ± 16.5
versus 90.7 ± 12.0 cm) (p< 0.001 for both). Notably, half of patients with HFpEF (54.7%) had
abdominal obesity (WHtR > 0.60), in contrast to a quarter of HFrEF patients (23%) (S4 Table
and Fig 2).
Results with increasing BMI quartiles when restricted to patients with waist measures (n =
2,051; S4 Table) were similar to those in the larger cohort (n = 5,964; S2 Table), as described
above. Larger WHtR (increasing WHtR quartiles) was associated with a higher proportion of
women, higher BMI, and higher prevalence of hypertension, diabetes, and peripheral oedema
(ptrend < 0.001; S4 Table). The highest WHtR quartile was associated with the lowest QoL over-
all summary score (63.3 ± 23.5), more so in HFpEF than HFrEF (pinteraction = 0.037).
Association of obesity with heart failure outcomes in Asia
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In combined analyses of BMI and WHtR (Table 1), lean-fat (low BMI/high WHtR) patients
(13.9%) had the highest proportion of women (35.4%), hypertension (55.1%), and diabetes
Fig 2. Prevalence of HFpEF and HFrEF stratified by body mass index and waist-to-height ratio. HFpEF, heart failure with preserved
ejection fraction; HFrEF, heart failure with reduced ejection fraction.
https://doi.org/10.1371/journal.pmed.1002916.g002
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(46.0%); were more likely to be from low-income countries or to be from South Asia or South-
east Asia; and had the lowest QoL scores (5–9 points lower than other groups), with respect to
the self-efficacy (63.7 ± 29.1) and social limitation (59.9 ± 32.7) domains (p< 0.05).
Overall obese (high BMI/high WHtR) patients (36.3%) were more likely to have HFpEF
(11.8%), to be from South Asia/Southeast Asia, and to have hypertension (60.6%) and periph-
eral oedema (25.1%) (p< 0.001 for all; Table 1).
Overall lean (low BMI/low WHtR) patients (36.0%) were more likely to have HFrEF
(97.1%) and to be from Northeast Asia (24.4%), and had the lowest prevalence of comorbidi-
ties (hypertension, 43.8%; diabetes, 31.1%), compared to the other groups (p< 0.001).
Obese-thin (high BMI/low WHtR) patients (13.8%) were younger, were more often men,
and had the highest QoL scores, compared to the other groups. The obese-thin patients also
had lower prevalence of hypertension (53.5% versus 60.6%), compared to the overall obese (p
< 0.05; Table 1).
Body composition analysis
Among the 311 patients with additional bioelectrical impedance data, baseline characteristics
were similar to the overall cohort (S5 Table). Patients who were overall obese (high BMI/high
waist-to-hip ratio) had the highest percentage fat mass and trunk fat, followed by obese-thin
(high BMI/low waist-to-hip ratio), lean-fat (low BMI/high waist-to-hip ratio), and overall lean
(low BMI/low waist-to-hip ratio) (p< 0.001; S5 Table). Controlled for BMI, sex, and age, a
1-SD increase in waist-to-hip ratio was associated with a 0.38-unit increase in percent trunk
fat (p< 0.05).
Clinical outcomes and quality of life
Of the 2,051 Asian patients with both BMI and WHtR measurements available, follow-up data
were complete in 1,746 (85.1%) patients, of whom 285 (16.3%) experienced the primary com-
posite outcome of all-cause mortality or hospitalisation for HF within 1 year, and 190 (10.9%)
patients died within 1 year.
Cubic spline regression models showed an inverse relationship between BMI and risk of
the composite outcome; in contrast, there was a direct relationship between WHtR and risk of
the composite outcome. The associations of BMI and WHtR with the composite outcome
were not modified by HF subtype (i.e., HFpEF or HFrEF; pinteraction = 0.760 and 0.881 respec-
tively; Table 2). Our sensitivity analysis showed similar results for BMI when the entire cohort
with follow-up data was included (n = 5,397; S6 Table) and when using WHO-recommended
Asian BMI cutoffs (Fig 3).
Outcomes differed by BMI/WHtR groups. The risk of the composite outcome of death or
HF hospitalisation was highest in the lean-fat (low BMI/high WHtR) group (51/232, 22.0%) and
lowest in the obese-thin (high BMI/low WHtR) group (27/234, 11.5%). After adjustment for
age, sex, HF subtype, NYHA class, systolic blood pressure, heart rate, comorbidities, and HF
medications, the lean-fat (low BMI/high WHtR) group still had a higher risk of the composite
outcome (adjusted hazard ratio 1.93, 95% CI 1.17–3.18, p = 0.010) (Table 2), compared to the
obese-thin group. HF subtype (HFrEF or HFpEF) did not modify the association between the
BMI/WHtR groups and the 1-year composite outcome (pinteraction = 0.355) (Fig 4).
Similar patterns were observed with 1-year all-cause mortality and HF hospitalisation.
The mortality event rate (36/232, 15.5%) and adjusted risk of all-cause mortality were higher
in the lean-fat (low BMI/high WHtR) group (adjusted hazard ratio 2.01, 95% CI 1.11–3.65, p
= 0.022) than in the obese-thin group (Table 2). Results were similar in both HF subtypes
(p interaction = 0.609). Cardiovascular mortality was also higher in the lean-fat group (33/232,
Association of obesity with heart failure outcomes in Asia
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n 283 745 738 285
HFpEF 15 (5.3%) 88 (11.8%) 21 (2.9%) 15 (5.3%) <0.001
Demographics
Age, years 58.9 (12.7) 59.5 (12.6) 61.5 (13.4) 63.9 (11.9) <0.001
Women 39 (13.8%) 209 (28.1%) 144 (19.5%) 101 (35.4%) <0.001
Ethnicity 0.011
Chinese 57 (20.1%) 177 (23.8%) 175 (23.7%) 66 (23.2%)
Indian 113 (39.9%) 308 (41.3%) 279 (37.8%) 123 (43.2%)
Malay 42 (14.8%) 86 (11.5%) 77 (10.4%) 38 (13.3%)
Japanese/Korean 23 (8.1%) 56 (7.5%) 93 (12.6%) 32 (11.2%)
Other (Thai, Filipino, indigenous) 48 (17.0%) 118 (15.8%) 114 (15.4%) 26 (9.1%)
Geographical region, percent 0.028
Northeast Asia 56 (19.8%) 130 (17.4%) 180 (24.4%) 51 (17.9%)
South Asia 98 (34.6%) 279 (37.4%) 261 (35.4%) 114 (40.0%)
Southeast Asia 129 (45.6%) 336 (45.1%) 297 (40.2%) 120 (42.1%)
Country-level economic development <0.001
Low income 111 (39.2%) 316 (42.4%) 304 (41.2%) 136 (47.7%)
Middle income 118 (41.7%) 217 (29.1%) 236 (32.0%) 52 (18.2%)
High income 54 (19.1%) 212 (28.5%) 198 (26.8%) 97 (34.0%)
Clinical characteristics
NYHA 0.740
Class I or II 179 (69.6%) 483 (69.7%) 467 (67.1%) 187 (68.2%)
Class III or IV 78 (30.4%) 210 (30.3%) 229 (32.9%) 87 (31.8%)
Systolic blood pressure, mm Hg 120.2 (18.6) 122.7 (20.2) 115.0 (18.9) 120.3 (19.3) <0.001
Diastolic blood pressure, mm Hg 73.5 (11.7) 74.1 (12.2) 71.2 (11.3) 71.4 (11.5) <0.001
Heart rate, bpm 78.9 (15.9) 79.3 (14.8) 78.8 (15.0) 77.7 (13.0) 0.500
BMI, kg/m2 26.6 (2.6) 29.6 (5.1) 21.0 (2.1) 22.1 (1.8) <0.001
eGFR, ml/min/1.73 m2 64.4 (26.1) 65.8 (28.4) 65.9 (26.8) 64.1 (29.5) 0.770
Comorbidities
Chronic kidney disease (eGFR < 60 ml/min/
1.73 m2)
85 (45.0%) 252 (44.4%) 231 (40.7%) 113 (47.7%) 0.280
Ischemic HF 139 (49.1%) 351 (47.1%) 366 (49.7%) 144 (50.5%) 0.610
Hypertension 151 (53.5%) 451 (60.6%) 322 (43.8%) 157 (55.1%) <0.001
Coronary artery disease 145 (51.4%) 380 (51.1%) 384 (52.2%) 152 (53.3%) 0.920
Atrial fibrillation 31 (11.0%) 119 (16.0%) 118 (16.0%) 48 (16.8%) 0.170
Myocardial infarction 91 (32.3%) 235 (31.6%) 234 (31.8%) 90 (31.6%) 0.997
Diabetes 127 (45.0%) 339 (45.6%) 229 (31.1%) 131 (46.0%) <0.001
Prior stroke 16 (5.7%) 55 (7.4%) 36 (4.9%) 25 (8.8%) 0.076
Peripheral artery vascular disease 6 (2.1%) 19 (2.6%) 22 (3.0%) 10 (3.5%) 0.740
Peripheral oedema 55 (19.4%) 187 (25.1%) 125 (17.0%) 55 (19.3%) 0.001
COPD 16 (5.7%) 53 (7.1%) 54 (7.3%) 23 (8.1%) 0.720
Smoking, ever 134 (47.5%) 318 (42.7%) 347 (47.2%) 109 (38.2%) 0.034
Alcohol, ever 78 (27.7%) 215 (28.9%) 215 (29.3%) 67 (23.5%) 0.290
Medications
ACEi or ARB 209 (74.9%) 543 (74.4%) 513 (70.8%) 188 (68.9%) 0.170
Beta blocker 211 (75.6%) 569 (77.9%) 530 (73.1%) 194 (71.1%) 0.070
(Continued)
Association of obesity with heart failure outcomes in Asia
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002916 September 24, 2019 9 / 17
14.5%) than in the obese-thin group (p = 0.026; Table 1). In sex-stratified analysis, higher
WHtR (�0.60) was associated with higher risk of death in both men and women, as observed
in the overall cohort. However, our current study is underpowered to have such sex-specific
conclusions statistically confirmed, as evident from the low number of events and large confi-
dence intervals, especially in women (S7 Table).
With regards to QoL, the adjusted mean overall scores were not different between the 4
groups (p = 0.544). The lean-fat (low BMI/high WHtR) patients had lower adjusted mean
social limitation scores compared to the obese-thin (high BMI/low WHtR) patients (61.9 ver-
sus 67.5, p = 0.034), while the difference in self-efficacy scores was attenuated after adjustment
for demographic and clinical confounders (p = 0.510) (Table 3).
Discussion
To our knowledge, this study provides the first prospective multinational data on the associa-
tion of BMI versus WHtR with outcomes among Asian patients with HFpEF and HFrEF. We
found a number of interesting results. First, BMI and abdominal obesity have directionally
opposite relationships with outcomes—lower BMI, but higher WHtR, was associated with
worse outcomes. Second, patients who were lean-fat (low BMI/high WHtR) were more likely
to be women, to be from low-income countries or South/Southeast Asia, and to have the high-
est burden of diabetes, poorest QoL, and worst composite outcome. Third, results were consis-
tent regardless of type of HF (HFpEF or HFrEF).
Previous reports on obesity and clinical outcomes in HF have predominantly relied on a
















Diuretic 207 (74.2%) 632 (86.6%) 599 (82.6%) 225 (82.4%) <0.001
MRA 149 (53.4%) 379 (51.9%) 406 (56.0%) 134 (49.1%) 0.200
Outcomes at 1 year
All-cause mortality 19 (8.1%) 62 (9.4%) 73 (11.7%) 36 (15.5%) 0.031
Cardiovascular mortality 18 (7.8%) 52 (8.1%) 63 (10.6%) 33 (14.5%) 0.026
Composite outcome (all death + HF
hospitalisation)
27 (11.5%) 103 (15.6%) 104 (16.7%) 51 (22.0%) 0.022
Quality of life at baseline (n = 1,990)
Physical limitation score 70.3 (25.2) 71.5 (24.4) 71.2 (25.6) 67.8 (27.5) 0.210
Symptom stability score 62.4 (26.7) 59.8 (27.3) 61.4 (27.7) 64.3 (28.1) 0.110
Symptom frequency score 72.3 (28.3) 70.0 (28.3) 71.5 (27.0) 69.1 (28.6) 0.430
Symptom burden score 75.4 (27.4) 74.5 (26.2) 74.0 (25.6) 71.7 (27.7) 0.380
Total symptom score 73.8 (27.0) 72.2 (26.2) 72.7 (25.5) 70.4 (27.4) 0.470
Self-efficacy score 68.9 (26.4) 67.7 (27.3) 64.7 (27.4) 63.7 (29.1) 0.027
Social limitation score 68.8 (30.0) 65.4 (31.5) 63.2 (33.2) 59.9 (32.7) 0.011
Overall summary score 67.7 (22.4) 66.4 (22.6) 65.6 (23.0) 63.3 (24.2) 0.130
Clinical summary score 72.1 (23.3) 71.9 (22.5) 72.0 (22.8) 69.1 (24.9) 0.300
Data given as mean (standard deviation) or number (percent).
ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BMI, body mass index; COPD, chronic obstructive pulmonary disease; eGFR,
estimated glomerular filtration rate; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; MRA, mineralocorticoid receptor antagonist; NYHA, New
York Heart Association; WHtR, waist-to-height ratio.
https://doi.org/10.1371/journal.pmed.1002916.t001
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Table 2. Association of BMI and WHtR with outcomes.
Outcome by BMI and WHtR Number at
risk
Number of events, n
(%)
Unadjusted hazard ratio (95%
CI)




BMI and WHtR 0.017† 0.058†
Obese-thin (high BMI, low WHtR) 234 27 (11.5%) 1.00 (Reference) 1.00 (Reference)
Overall obese (high BMI, high WHtR) 658 103 (15.6%) 1.40 (0.92, 2.14) 0.121 1.52 (0.97, 2.40) 0.068
Overall lean (low BMI, low WHtR) 622 104 (16.7%) 1.52 (1.00, 2.32) 0.051 1.63 (1.03, 2.56) 0.035
Lean-fat (low BMI, high WHtR) 232 51 (22.0%) 2.07 (1.30, 3.29) 0.002 1.93 (1.17, 3.18) 0.010
1-year all-cause mortality
BMI and WHtR 0.025† 0.034†
Obese-thin (high BMI, low WHtR) 234 19 (8.1%) 1.00 (Reference) 1.00 (Reference)
Overall obese (high BMI, high WHtR) 658 62 (9.4%) 1.17 (0.70, 1.96) 0.545 1.21 (0.70, 2.09) 0.504
Overall lean (low BMI, low WHtR) 622 73 (11.7%) 1.49 (0.90, 2.47) 0.121 1.67 (0.97, 2.87) 0.065
Lean-fat (low BMI, high WHtR) 232 36 (15.5%) 2.04 (1.17, 3.55) 0.012 2.01 (1.11, 3.65) 0.022
1-year HF hospitalisation
BMI and WHtR 0.103† 0.207†
Obese-thin (high BMI, low WHtR) 234 10 (4.3%) 1.00 (Reference) 1.00 (Reference)
Overall obese (high BMI, high WHtR) 658 50 (7.6%) 1.81 (0.92,3.57) 0.088 1.84 (0.90, 3.79) 0.096
Overall lean (low BMI, low WHtR) 622 45 (7.2%) 1.72 (0.87, 3.42) 0.120 1.59 (0.78, 3.42) 0.203
Lean-fat (low BMI, high WHtR) 232 24 (10.3%) 2.51 (1.20, 5.24) 0.015 1.99 (0.91, 4.35) 0.083
�Adjusted for age, sex, ethnicity, enrolment type, New York Heart Association class, systolic blood pressure, heart rate, ejection fraction, history of coronary artery
disease, atrial fibrillation, diabetes, peripheral oedema, peripheral artery vascular disease, and use of angiotensin-converting enzyme inhibitor/angiotensin receptor
blocker, beta blocker, diuretic, and mineralocorticoid receptor antagonist.
†Overall type III p-values for BMI/WHtR groups.
BMI, body mass index; WHtR, waist-to-height ratio.
https://doi.org/10.1371/journal.pmed.1002916.t002
Fig 3. Association of BMI and waist-to-height ratio with the composite outcome using cubic spline regression
models and Cox proportional hazards models. Cubic spline regression models (A and C); Cox proportional hazards
models (B and D). HR, hazard ratio.
https://doi.org/10.1371/journal.pmed.1002916.g003
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WHtR) or examined these measurements in isolation from one another. Studies solely using
BMI have consistently reported an obesity paradox, with overweight and obese patients with
HF having better prognosis than their lean counterparts in both HFpEF and HFrEF [4–6,11].
Fig 4. Kaplan–Meier survival curves of the composite outcome for combined BMI/WHtR groups. BMI, body mass
index; WHtR, waist-to-height ratio.
https://doi.org/10.1371/journal.pmed.1002916.g004
Table 3. Adjusted mean Kansas City Cardiomyopathy Questionnaire domain scores, by BMI/WHtR group.
Quality of life domains Obese-thin
(high BMI, low WHtR)
Overall obese
(high BMI, high WHtR)
Overall lean
(low BMI, low WHtR)
Lean-fat
(low BMI, high WHtR)
p-Value
n 264 726 718 282
Physical limitation score 69.0 (1.4) 71.0 (0.9) 71.2 (0.9) 69.3 (1.4) 0.396
Symptom stability score 62.8 (1.8) 60.7 (1.1) 61.5 (1.1) 64.6 (1.7) 0.241
Symptom frequency score 71.1 (1.5) 69.9 (0.9) 70.9 (0.9) 70.0 (1.4) 0.836
Symptom burden score 74.1 (1.5) 74.3 (0.9) 73.5 (0.9) 72.7 (1.4) 0.780
Total symptom score 72.6 (1.4) 72.1 (0.9) 72.2 (0.9) 71.4 (1.4) 0.934
Self-efficacy score 67.5 (1.6) 66.8 (1.0) 65.3 (1.0) 65.0 (1.5) 0.510
Social limitation score 67.5 (1.9) 65.1 (1.2) 63.1 (1.1)� 61.9 (1.9)� 0.102
Overall summary score 66.6 (1.2) 66.1 (0.8) 65.4 (0.7) 64.4 (1.2) 0.544
Clinical summary score 70.7 (1.2) 71.6 (0.7) 71.7 (0.7) 70.3 (1.2) 0.711
Data presented are adjusted mean scores (standard error of mean) (adjusted for age, sex, ethnicity, enrolment type, education, New York Heart Association class,
systolic blood pressure, heart rate, heart failure subtype, history of coronary artery disease, atrial fibrillation, and diabetes).
�p< 0.05 compared against the obese-thin group.
BMI, body mass index; WHtR, waist-to-height ratio.
https://doi.org/10.1371/journal.pmed.1002916.t003
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However, more recent reports using measures of abdominal obesity have challenged this con-
cept. Unlike for BMI, higher waist circumference was associated with higher risk of mortality
across a wide range of left ventricular EF values [14], particularly HFpEF [13]. A combined
measure of BMI and waist circumference showed higher risk of mortality in overall obese
patients with high BMI and high waist circumference [19]. However, this was a single-centre
study (n = 344) that included only patients with HFrEF. Our findings extend the prior litera-
ture by showing the association of combined measures of BMI/WHtR and outcomes in a
large, well-characterised multinational Asian cohort of patients with HFrEF and HFpEF.
Our most striking finding is that BMI and WHtR have directionally contrasting relation-
ships with clinical outcomes—higher BMI is associated with better, and higher WHtR with
worse, outcomes. Despite lower BMI on average in Asian patients with HF compared to West-
ern cohorts, we confirmed that the obesity paradox still applies to the Asian HF population
when BMI is used to index obesity. This is consistent with limited previous reports from East
Asia [7,8], but our data are the first to our knowledge available from wider geography includ-
ing Southeast and South Asia. Higher metabolic reserve in face of the catabolic effects of HF is
suggested as an explanation for the BMI paradox [10]. Although BMI is a convenient measure,
it is known that it fails to distinguish between (1) components of body composition (fat mass,
lean mass, skeletal muscle mass), (2) different body fat distributions (central versus peripheral
adipose depots), and (3) fluid accumulation in decompensated HF and absolute weight gain
[10].
In contrast to the findings for BMI, we observed that higher WHtR was associated with
higher 1-year mortality and composite outcome, similar to some previous studies [13,14] but
not others [19]. Consistent with our findings, higher waist circumference was associated with
higher risk of all-cause mortality in the pure HFpEF cohort of TOPCAT, despite a strong para-
doxical relationship between BMI and outcomes [13]. In the European BIOSTAT-CHF HF
population [14], an association between higher waist-to-hip ratio and higher mortality was
observed only in women, whereas we found similar associations in men and women in
ASIAN-HF (i.e., sex did not modify the relationship between WHtR and outcomes in our
study; pinteraction > 0.5). One other single-centre study, including only patients with HFrEF (n
= 344) [19], reported contrary results in that HFrEF patients with normal BMI/normal waist
circumference had the highest hazards of 2-year mortality compared to those with high BMI/
high waist circumference—discordant results that may be due to exclusion of lean patients
(with BMI < 18.5 kg/m2) and patients with HFpEF, in whom prevalence of central obesity is
higher. Importantly, our study is the first demonstration to our knowledge of the impact of
WHtR, an index of central obesity, on HF outcomes in Asia. While there was greater preva-
lence of central obesity among patients with HFpEF than HFrEF, it was equally associated
with worse outcomes in both HF subtypes. Indeed, abdominal measures of adiposity (waist
circumference, waist-to-hip ratio, WHtR) more accurately reflect body composition than BMI
[20]. Mechanistic insights into abdominal adiposopathy include suggestions of a pro-inflam-
matory pathology. Adipose tissues actively produce inflammatory cytokines, potentially lead-
ing to diastolic dysfunction [21]. Experimental models have shown strong relationships
between visceral obesity and increased cardiac macrophage infiltration and cytokine gene
expression, exacerbating myocardial hypertrophy, fibrosis, and injury [22].
Our findings highlight a particularly susceptible group of lean-fat (low BMI/high WHtR)
patients who were more likely to be women, with a higher prevalence of diabetes, poorer QoL
scores, and worse composite outcome, compared to all other groups. Central adiposity is asso-
ciated with cardiac dysfunction, independent of BMI, even in lean individuals [23]. The thrifty
gene hypothesis, maternal insufficiency, foetal undernutrition, and differences in body fat dis-
tribution have been suggested to contribute to the higher prevalence of lean diabetes in Asia
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[24,25]. Our preliminary evidence from body composition analysis showing that higher waist-
to-hip ratio was independently linked with higher trunk fat and lower skeletal muscle mass
suggests the presence of sarcopenia in the lean-fat patients. Whether sarcopenia may be a treat-
able target in HF remains to be proven. Interestingly, the commonly observed BMI paradox is
obliterated when cardiorespiratory fitness is increased/preserved [26], presumably due to pres-
ervation of skeletal muscle mass. It is also noteworthy that most of the lean-fat patients in our
study were from South Asia and Southeast Asia, while patients from Northeast Asia were more
likely to be overall lean. Indeed, ethnic differences in body fat distribution have been reported
previously in the INSPIRE ME IAA study, which included white, black, Hispanic, East Asian,
and South Asian individuals. CT-scan assessment revealed that East Asians, followed by South
Asians, had a more detrimental abdominal fat deposition, despite low BMI [27].
Asians exhibit remarkable variability in body fat distribution for a given BMI, and viscerally
obese patients with HF have the worst outcomes. Information from a single anthropometric
measure in isolation fails to provide the necessary insights into body fat distribution. More
accurate estimators of visceral fat, such as computer tomography scans, magnetic resonance
imaging, and dual energy X-ray absorptiometry, are cost intensive or involve the risk of radia-
tion [10]. Whilst not perfect, a combination measure of BMI and WHtR is a simple and conve-
nient alternative for estimation of body fat distribution. Targeting visceral obesity with
inhibitors of aldosterone, neprilysin, and, particularly, sodium glucose transporter 2 (SGLT2)
have been suggested for management of obesity-related HF, pending confirmation from ongo-
ing large-scale trials [28].
Strengths and limitations
Selection bias and residual confounding are inevitable in such multinational observational
studies. Lack of repeat assessments of BMI or waist measures precludes any inferences involv-
ing loss of muscle mass in the progression of HF. Unmeasured factors such as differences in
healthcare system, economic development, and nutritional status across the regions are poten-
tial confounders. Patients with body composition analysis are more recent recruits who do not
have follow-up data available for outcome analysis. Key strengths of this study include the pro-
spective design, that the study spans across widespread geography in Asia (46 centres from 11
regions), uniform data collection, meticulous follow-up, and independent adjudication of out-
comes. We utilised abdominal measures and body composition data in addition to BMI to
investigate the obesity paradox in both HFpEF and HFrEF in Asia.
Implications and next steps
Obesity in HF poses formidable public health challenges for health policymakers, health ser-
vice providers, and patient caregivers in many low- and middle-income countries. The contro-
versy surrounding the obesity paradox makes it even more challenging for clinicians to
manage concomitant HF and obesity. Combined usage of BMI and abdominal measures could
potentially inform HF management better, especially among the particularly vulnerable
patients with low BMI and high WHtR. Clear national policies that underscore prevention of
abdominal obesity and promotion of a healthy BMI, through awareness, education, and life-
style modification, need to be championed.
Conclusion
Among Asian patients with HF, we observed that higher BMI was associated with better out-
comes whereas higher WHtR conferred worse outcomes. Our findings highlight a particularly
susceptible group of lean-fat (low BMI/high WHtR) patients who were more likely to be
Association of obesity with heart failure outcomes in Asia
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women, with a higher prevalence of diabetes, poorer QoL scores, and worse composite out-
come, compared to all other groups.
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